Incorporating monoclonal antibodies into the first-line treatment of classical Hodgkin lymphoma
TP Vassilakopoulos, A Liaskas, P Pereyra… - International Journal of …, 2023 - mdpi.com
The long-term survival of Hodgkin lymphoma (HL) patients treated according to the current
standard of care is excellent. Combined-modality schedules (ABVD plus radiotherapy) in …
standard of care is excellent. Combined-modality schedules (ABVD plus radiotherapy) in …
Sequencing novel agents in the treatment of classical Hodgkin lymphoma
B Ferhanoglu, M Ozbalak - Expert Review of Hematology, 2023 - Taylor & Francis
ABSTRACT Introduction Classical Hodgkin lymphoma (cHL) is a curable disease, with
durable remission achieved in about 80% of patients following first-line treatment. Three …
durable remission achieved in about 80% of patients following first-line treatment. Three …